Deutsche Bank analyst Nicole Deblase maintains Stanley Black & Decker (NYSE:SWK) with a Hold and lowers the price target from $111 to $90.
Reported Late Thursday, Prometheus Biosciences Announces Pricing Of Public Upsized $500M Offering Of 4,545,455 Shares Of Common Stock At A Price Of $110/Share
Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion
